Grants

Active Grants 

1. Canadian Institutes of Health Research, Partnership in Health System Improvement
Title: Empowering Patients as Active Partners in Their Care: Lupus Interactive Navigator (LIN)
Principal applicants: Paul Fortin, Louise Bergeron
Term : April 2011- March 2014


2. Agency: The Arthritis Society (TAS)
Title: The Role of Fatty Acid Composition in Disease Activity and Cardiovascular Disease in Systemic Lupus Erythematosus
Principal Applicants: Paul Fortin, Ellie Aghdassi
Term: October 2010 - March 2013


3. Agency: Mary Kirkland Lupus Foundation
Title: Lupus Clinical Trials Consortium (LCTC)
Principal Applicants: Paul R. Fortin on behalf of CaNIOS,
Term: 2004-present


Grants Held


1. Agency: Canadian Institutes of Health Research (CIHR)
Title: The e-LHP: Dissemination of the Lupus Health Passport
Principal Applicant: Paul Fortin
Term: April 2010 - March 2011


2. Agency: Canadian Institutes of Health Research
Title: Learning to live better with lupus: The health improvement and prevention program (HIPP) in systemic lupus erythematosus
Principal Applicants: Paul R. Fortin, Deborah DaCosta, Michal Abrahamovicz, Ann E. Clarke, Susan E. Abbey, Robert M. Iwanochko, Paula J. Harvey, Samuel C. Siu
Term: 2007-2011


3. Agency: Canadian Institutes of Health Research (IMHA)
Title: Lupus Nephritis – New Emerging Team. (LuNNET)
Principal Applicant: Paul Fortin, Joan Wither, John Wilkins, Andrew Herzenberg, James Scholey, Joyce Rauch, Christian Pineau, Ann Clarke, Lawrence Joseph
Term: July 2005 – June 2010


4. Agency: Lupus Foundation of America
Title: Improving Transition Readiness and QoL with a Pediatric Health Passport
Principal Applicants: Dr. Emily Von Scheven with the support of CaNIOS
Term: October 2009 - September 2010

 
5. Agency: Canadian Institutes of Health Research
Title: The role of thrombophilic factors in persons with systemic lupus erythematosus
Principal Applicants: Paul Fortin, Jeannine Kassis, Joyce Rauch
Term: 2003-2008


6. Agency: Canadian Institutes of Health Research
Title: Genetic and environment factors in systemic lupus erythematosus (GenES Study)
Principal Applicants: Paul Fortin, Tom Hdson, Celia Greenwood, Joan Wither, Glinda Cooper
Term: 2003-2008


7. Agency: Institute of Musculoskeletal Health and Arthritis / The Arthritis Society
Title: The 1000 Canadian Faces of Lupus
Principal Applicants: Christine Peschken, Earl D. Silverman, Janet Pope, Glinda S. Cooper
Term: 2004-2007


8. Agency: Canadian Institutes of Health Research
Title: An international, multi-centre, prospective, inception cohort of neuropsychiatric systemic lupus erythematosus (NP-SLE)
Principal Applicants: John Hanly Murray Urowitz, Dafna Gladman, Paul Fortin, Ann Clarke, Vern Farewell
Term: 2002-2007


9. Agency: Institute of Musculoskeletal Health and Arthritis / The Arthritis Society
Title: Learning to live better with lupus: The health improvement and prevention program (HIPP) in systemic lupus erythematosus
Principal Applicants: Paul R. Fortin, Deborah DaCosta, Michal Abrahamovicz, Ann E. Clarke, Susan E. Abbey, Robert M. Iwanochko, Paula J. Harvey, Samuel C. Siu
Term: 2003-2006

 
10. Agency: Canadian Institutes of Health Research
Title: Malignancy in SLE: A proposal for a case-control study nested inside the cohort study
Principal Applicants: Ann E. Clarke
Term: 2003-2006


11. Agency: Canadian Institutes of Health Research
Title: The prevalence of risk factors for coronary artery disease in systemic lupus erythematosus: An international multi-centre prospective cohort study
Principal Applicants: Murray Urowitz, Ann E. Clarke, Dafna Gladman, Paul Fortin, John Hanly, Lori Tucker
Term: 2001-2006

 
12. Agency: National Cancer Institute of Canada
Title: Does systemic lupus erythematosus increase the risk of malignancy? An international multi-site retrospective cohort study
Principal Applicants: Ann Clarke, Lawrence Joseph, Jean-François Boivin, Raghu Rajan
Term: 2002-2005

 
13. Agency: Arthritis Foundation Clinical Science Grant
Title: An international study on the relative risk of malignancy in SLE
Principal applicants: Ann Clarke and Rosalind Ramsey-Goldman
Term: 2001-2004


14. Agency: Canadian Institutes of Health Research
Title: The Second Canadian Network for Improved Outcomes in SLE (CaNIOS) Principal Investigators Annual Meeting
Principal Applicants: Paul Fortin on behalf of CaNIOS
Term: 2003

 

15. Agency: La Jolla Pharmaceuticals
Title: Randomized, double-blind, placebo-controlled, multicenter safety and efficacy trial of LJP 394 in systemic lupus erythematosus (SLE) patients with a history of renal disease.
Term: 2000-2002

 
16. Agency: The Arthritis Society
Title: The risk of malignancy in patients with systemic lupus erythematosus
Principal Investigator: Ann Clarke
Term: 1999-2002


17. Agency: The Arthritis Society with co-sponsorship by Faulding Canada, Inc.
Title: A Canadian multicenter, randomized,double-blind placebo-controlled study of methotrexate and folic acid in systemic lupus erythematosus: A phase III trial. SMILE: Study of methrotrexate in lupus erythematosus
Principal Applicant: Paul Fortin
Term: 1995-2001 (renewal)

 
18. Agency: NHRDP
Title: Decreasing costs and improving outcomes in chronic diseases: Randomized multi-site trial of group psychotherapy for patients with systemic lupus erythematosus. (LEAP Study)
Principal Applicants: Patricia Dobkin and Ann Clarke
Term: 1996-2000


19. Agency: The Arthritis Society with co-sponsorship by Faulding Canada, Inc.
Title: A Canadian multicenter, randomized,double-blind placebo-controlled study of methotrexate and folic acid in systemic lupus erythematosus: A phase III trial. SMILE: Study of methrotrexate in lupus erythematosus
Principal Applicant: Paul Fortin
Term: 1995-1998